Novel LIFR Variant Identified in Stuve-Wiedemann Syndrome - Summary - MDSpire

Novel LIFR Variant Identified in Stuve-Wiedemann Syndrome

  • By

  • Henry Thomas

  • February 10, 2026

  • 2 min

Share

Objective:

To report a case of Stüve-Wiedemann syndrome in an infant and identify a novel LIFR variant, highlighting its significance in diagnosis and management.

Approach:
    Key Findings:
    • The identified variant (c.823G>T, p.Glu275Ter) is classified as likely pathogenic, indicating a significant risk for the patient.
    • Stüve-Wiedemann syndrome is characterized by bowed long bones, joint contractures, and severe dysautonomia, which complicates management.
    • The infant exhibited prenatal and postnatal symptoms consistent with the syndrome, including intrauterine growth restriction and feeding difficulties, which are critical for early intervention.
    • Dysautonomia is a significant contributor to early mortality, with a global mortality rate of 46%, emphasizing the need for vigilant monitoring.
    Interpretation:

    Molecular confirmation of LIFR variants can differentiate Stüve-Wiedemann syndrome from other skeletal dysplasias, aiding in accurate diagnosis and management strategies.

    Limitations:
    • The report is based on a single case, limiting generalizability; further studies are needed to validate findings.
    • Long-term outcomes and survival rates require further investigation to inform clinical practice.
    Conclusion:

    While initially considered uniformly lethal, some patients may survive beyond the first two years of life, indicating a need for ongoing research into the condition to improve patient outcomes.

    Sources:

Original Source(s)

Related Content